The association between two genetic polymorphisms in
Cancer
Eastern Province
Genetic Polymorphisms
ITGB3 gene
Risk
Saudi Arabia
Venous Thromboembolism
Journal
Saudi journal of biological sciences
ISSN: 1319-562X
Titre abrégé: Saudi J Biol Sci
Pays: Saudi Arabia
ID NLM: 101543796
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
01
06
2021
revised:
20
08
2021
accepted:
22
08
2021
entrez:
10
1
2022
pubmed:
11
1
2022
medline:
11
1
2022
Statut:
ppublish
Résumé
Venous thromboembolism (VTE) is one of the major complications in most cancer patients leading to poor prognosis and short survival. Several common clinical risk factors coexist in cancer patients are used as risk predictive biomarkers to help in the management and prevention of VTE. These include cancer site and stage, chemotherapy regimen and elevated biological markers. However, Genetic polymorphisms in genes controlling coagulation and fibrinolysis
Identifiants
pubmed: 35002407
doi: 10.1016/j.sjbs.2021.08.073
pii: S1319-562X(21)00762-2
pmc: PMC8716864
doi:
Types de publication
Journal Article
Langues
eng
Pagination
183-189Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Cancer Res Ther. 2019;15(2):344-349
pubmed: 30964109
Thromb Res. 2015 Nov;136(5):865-9
pubmed: 26440977
Semin Thromb Hemost. 2017 Jul;43(5):469-478
pubmed: 28264198
Hematology Am Soc Hematol Educ Program. 2013;2013:684-91
pubmed: 24319253
Blood. 2021 Apr 8;137(14):1959-1969
pubmed: 33171494
Intern Emerg Med. 2014 Aug;9(5):559-67
pubmed: 23943559
Cancers (Basel). 2018 Dec 10;10(12):
pubmed: 30544670
J Cardiol. 2020 Jan;75(1):110-114
pubmed: 31416782
Cancers (Basel). 2018 Oct 11;10(10):
pubmed: 30314362
Br J Cancer. 2018 Apr;118(8):1056-1061
pubmed: 29588512
Eur Respir Rev. 2019 Mar 27;28(151):
pubmed: 30918022
Blood. 2001 May 15;97(10):3093-9
pubmed: 11342435
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
J Hematol Oncol. 2019 Mar 7;12(1):26
pubmed: 30845955
J Clin Oncol. 2009 Oct 10;27(29):4839-47
pubmed: 19720906
Thromb Res. 2016 Apr;140 Suppl 1:S12-7
pubmed: 27067965
Biomed Res Int. 2016;2016:5675084
pubmed: 27965976
BMC Cancer. 2014 Nov 19;14:845
pubmed: 25407022
Clin Appl Thromb Hemost. 2017 Sep;23(6):585-595
pubmed: 26739544
Indian J Hematol Blood Transfus. 2015 Dec;31(4):439-45
pubmed: 26306068
Arch Med Sci Atheroscler Dis. 2016 Apr 27;1(1):e9-e15
pubmed: 28905013
Haematologica. 2019 Jun;104(6):1277-1287
pubmed: 30606788
Ann Palliat Med. 2021 Jun;10(6):6957-6967
pubmed: 34118860
Oncologist. 2017 Feb;22(2):199-207
pubmed: 28174293
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S178-S185
pubmed: 29399521
Curr Pharm Des. 2004;10(14):1567-76
pubmed: 15134555
Pharmacogenomics J. 2011 Oct;11(5):348-58
pubmed: 20548328
Acta Med Port. 2019 Oct 1;32(10):647-653
pubmed: 31625877
Thromb Res. 2018 Apr;164 Suppl 1:S12-S18
pubmed: 29703469
Exp Ther Med. 2019 Dec;18(6):5026-5032
pubmed: 31819767
Asian Pac J Cancer Prev. 2012;13(4):1311-5
pubmed: 22799324
Blood. 2013 Sep 5;122(10):1712-23
pubmed: 23908465
World J Surg Oncol. 2015 Jun 20;13:204
pubmed: 26092573